Diovan HCT is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is Valsartan; Hydrochlorothiazide.
Product ID | 0078-0383_0fa1a408-909e-4098-96ac-2bef1bd97298 |
NDC | 0078-0383 |
Product Type | Human Prescription Drug |
Proprietary Name | Diovan HCT |
Generic Name | Valsartan And Hydrochlorothiazide |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 1998-03-06 |
Marketing Category | NDA / NDA |
Application Number | NDA020818 |
Labeler Name | Novartis Pharmaceuticals Corporation |
Substance Name | VALSARTAN; HYDROCHLOROTHIAZIDE |
Active Ingredient Strength | 160 mg/1; mg/1 |
Pharm Classes | Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 1998-03-06 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA020818 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2010-04-06 |
Marketing Category | NDA |
Application Number | NDA020818 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 1998-03-06 |
Marketing End Date | 2017-05-31 |
Marketing Category | NDA |
Application Number | NDA020818 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 1998-03-06 |
Marketing Category | NDA |
Application Number | NDA020818 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2011-01-25 |
Marketing End Date | 2015-08-10 |
Marketing Category | NDA |
Application Number | NDA020818 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2010-08-29 |
Marketing End Date | 2015-08-10 |
Marketing Category | NDA |
Application Number | NDA020818 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 1998-03-06 |
Marketing End Date | 2015-08-10 |
Ingredient | Strength |
---|---|
VALSARTAN | 160 mg/1 |
SPL SET ID: | d76a0419-05ee-437e-884c-65807aea9569 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
0078-0314 | Diovan HCT | valsartan and hydrochlorothiazide |
0078-0315 | Diovan HCT | valsartan and hydrochlorothiazide |
0078-0383 | Diovan HCT | valsartan and hydrochlorothiazide |
0078-0471 | Diovan HCT | valsartan and hydrochlorothiazide |
0078-0472 | Diovan HCT | valsartan and hydrochlorothiazide |
68258-6056 | Diovan HCT | Diovan HCT |
68258-6053 | Diovan HCT | Diovan HCT |
68258-6972 | Diovan HCT | Diovan HCT |
68258-6973 | Diovan HCT | Diovan HCT |
55289-820 | Diovan HCT | Diovan HCT |
55289-838 | Diovan HCT | Diovan HCT |
0378-6321 | Valsartan and Hydrochlorothiazide | valsartan and hydrochlorothiazide |
0378-6322 | Valsartan and Hydrochlorothiazide | valsartan and hydrochlorothiazide |
0378-6323 | Valsartan and Hydrochlorothiazide | valsartan and hydrochlorothiazide |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
DIOVAN HCT 75189097 2182834 Live/Registered |
NOVARTIS CORPORATION 1996-10-28 |